US regulators have approved GSK’s Exdensur treatment for severe asthma with an eosinophilic phenotype, marking the first ...

If the FeNO level is not raised, it is recommended that the patient be offered either a Long-Acting Muscarinic Antagonist ...

Sandoz Group Ltd ($SDZXF) announced an update on their ongoing clinical study. Study Overview: Sandoz Group Ltd is conducting a clinical study ...

AstraZeneca ($AZN) announced an update on their ongoing clinical study. In a recent clinical study update, AstraZeneca has completed a Phase 2a ...

UK's health regulator on Monday approved GSK's twice-yearly drug for use as an add-on treatment for asthma in patients aged ...

Asthma is a common prevalent chronic respiratory illness that affects millions of people all over the world in every age group. Asthma is defined as inflamed and constricted airways, causing repeated ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. This week’s issue of the prestigious medical journal the Lancet is ...

Monthly injection with tezepelumab helped 90% of patients with severe asthma reduce intake of daily steroid tablets. The corresponding study was published in The Lancet Respiratory Medicine .

The American Asthma Foundation and the UCSF Foundation invite the campus community and the public at large to a forum titled "Finding a Cure for Asthma" on Thursday, Jan. 24. The event, which begins ...

December 16 is National Chocolate-Covered Anything Day, which is either a celebration of culinary creativity or an excuse to ...

FeNO testing is increasingly recognized as a key first step in asthma assessment under the updated UK guidelines.

Despite the name, cardiac asthma isn’t a type of asthma. It refers to breathing difficulty caused by fluid buildup in the lungs as a result of heart failure. Cardiac asthma can be potentially life ...